Home LiteratureArticle Details
PMID: 16698992 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.

Journal of virology ·Vol. 80 ·No. 11 ·2006-06-00 ·Pages 5113-24

Jones JO, Arvin AM

Abstract

Varicella-zoster virus (VZV) is an alphaherpesvirus that causes varicella and herpes zoster. Using human cellular DNA microarrays, we found that many nuclear factor kappa B (NF-kappaB)-responsive genes were down-regulated in VZV-infected fibroblasts, suggesting that VZV infection inhibited the NF-kappaB pathway. The activation of this pathway causes a cellular antiviral response, including the production of alpha/beta interferon, cytokines, and other proteins that restrict viral infection. In these experiments, we demonstrated that VZV interferes with NF-kappaB activation in cultured fibroblasts and in differentiated epidermal cells in skin xenografts of SCIDhu mice infected in vivo. VZV infection of fibroblasts caused a transient nuclear translocation of p50 and p65, the canonical NF-kappaB family members. In a process that was dependent upon the presence of infectious VZV, these proteins rapidly became sequestered in the cytoplasm of VZV-infected cells. Exclusion of NF-kappaB proteins from nuclei was associated with the continued presence of IkappaBalpha, which binds p50 and p65 and prevents their nuclear accumulation. IkappaBalpha levels did not diminish even though the protein became phosphorylated and ubiquitinated, as determined based on detection of the characteristic high-molecular-weight form of the protein, and the 26S proteasome remained functional in VZV-infected cells. VZV infection also inhibited the characteristic degradation of IkappaBalpha that is induced by exposure of fibroblasts to tumor necrosis factor alpha. As expected, herpes simplex virus 1 caused the persistent nuclear translocation of NF-kappaB proteins, which has been shown to facilitate its replication, whereas VZV infection progressed without persistent NF-kappaB nuclear localization. We suggest that VZV has evolved a mechanism to limit host cell antiviral defenses by sequestering NF-kappaB proteins in the cytoplasm, a strategy that appears to be unique among the herpesviruses.

MeSH Terms
Cell Line Fibroblasts/metabolism,virology Herpesvirus 3, Human/genetics,growth & development,physiology Humans NF-kappa B/antagonists & inhibitors,metabolism
Chemicals
NF-kappa B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jones Jeremy O
Stanford University School of Medicine, 300 Pasteur Drive, Rm. G312, Stanford, CA 94305-5208, USA. [email protected]
Arvin Ann M
References (58)
58 references, click to expand
  1. Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C.
    J Virol. 2002 Nov;76(21):11012-23 PMID: 12368344
  2. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
    J Biol Chem. 2001 May 11;276(19):15920-8 PMID: 11278695
  3. Ubiquitin: not just for proteasomes anymore.
    Curr Opin Cell Biol. 2003 Apr;15(2):184-90 PMID: 12648674
  4. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).
    Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9399-404 PMID: 15190178
  5. Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication.
    Virology. 1998 Aug 1;247(2):212-22 PMID: 9705914
  6. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.
    Oncogene. 1999 Oct 14;18(42):5738-46 PMID: 10523854
  7. NF-kappaB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-gamma-induced nitric oxide production in macrophages.
    J Gen Virol. 1998 Nov;79 ( Pt 11):2785-93 PMID: 9820155
  8. Activation and inhibition of virus and interferon: the herpesvirus story.
    Viral Immunol. 2002;15(1):3-15 PMID: 11952145
  9. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.
    J Biol Chem. 2002 Apr 19;277(16):13745-51 PMID: 11830587
  10. Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis.
    Transplantation. 2004 Jul 15;78(1):41-9 PMID: 15257037
  11. Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.
    J Virol. 2004 Mar;78(6):3190-5 PMID: 14990741
  12. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo.
    J Virol. 2003 Jan;77(2):1268-80 PMID: 12502844
  13. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.
    Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825-9 PMID: 1350676
  14. Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.
    J Virol. 2003 Jan;77(1):489-98 PMID: 12477854
  15. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.
    J Virol. 1995 Sep;69(9):5391-400 PMID: 7636984
  16. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.
    J Biol Chem. 2003 Dec 19;278(51):51134-42 PMID: 14532284
  17. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.
    J Virol. 2004 Feb;78(4):1675-84 PMID: 14747533
  18. Herpes simplex virus ICP0 mutants are hypersensitive to interferon.
    J Virol. 2000 Feb;74(4):2052-6 PMID: 10644380
  19. Cells lacking NF-kappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus.
    J Virol. 2004 Nov;78(21):11615-21 PMID: 15479802
  20. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.
    J Virol. 2002 Feb;76(4):1995-8 PMID: 11799195
  21. Failure of measles virus to activate nuclear factor-kappa B in neuronal cells: implications on the immune response to viral infections in the central nervous system.
    J Immunol. 1999 Apr 1;162(7):4024-9 PMID: 10201924
  22. Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.
    J Biol Chem. 2001 Aug 3;276(31):28759-66 PMID: 11387335
  23. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
    Biochem J. 2004 Sep 1;382(Pt 2):393-409 PMID: 15214841
  24. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.
    Science. 2002 Nov 8;298(5596):1241-5 PMID: 12424381
  25. An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages.
    J Virol. 1996 Dec;70(12):8527-33 PMID: 8970976
  26. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.
    Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7 PMID: 10920188
  27. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Nature. 2003 Aug 14;424(6950):801-5 PMID: 12917691
  28. KSHV vFLIP binds to IKK-gamma to activate IKK.
    J Cell Sci. 2003 Sep 15;116(Pt 18):3721-8 PMID: 12890756
  29. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.
    Science. 2000 Sep 1;289(5484):1560-3 PMID: 10968793
  30. Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein.
    J Biol Chem. 1998 Feb 27;273(9):5405-11 PMID: 9479002
  31. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice.
    J Virol. 1995 Sep;69(9):5236-42 PMID: 7636965
  32. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15595-600 PMID: 14673102
  33. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.
    J Virol. 2000 Dec;74(24):11566-73 PMID: 11090154
  34. Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB.
    J Biol Chem. 2003 Sep 19;278(38):36059-67 PMID: 12844494
  35. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
    J Clin Invest. 2001 Feb;107(3):241-6 PMID: 11160144
  36. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
    Nature. 1997 Aug 7;388(6642):548-54 PMID: 9252186
  37. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
    Antiviral Res. 2005 Nov;68(2):56-65 PMID: 16118026
  38. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway.
    J Virol. 2004 Dec;78(24):13582-90 PMID: 15564469
  39. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.
    J Exp Med. 2004 Oct 4;200(7):917-25 PMID: 15452178
  40. mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease.
    J Virol. 2002 Sep;76(17):8560-71 PMID: 12163576
  41. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.
    Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8 PMID: 9023344
  42. Regulation of JAK-STAT signalling in the immune system.
    Nat Rev Immunol. 2003 Nov;3(11):900-11 PMID: 14668806
  43. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
    Annu Rev Immunol. 1998;16:225-60 PMID: 9597130
  44. Nf-kappa B, chemokine gene transcription and tumour growth.
    Nat Rev Immunol. 2002 Sep;2(9):664-74 PMID: 12209135
  45. Activities of heterodimers composed of DNA-binding- and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4.
    J Virol. 1991 Jan;65(1):299-307 PMID: 1845890
  46. Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.
    Cytokine Growth Factor Rev. 1996 Aug;7(2):175-90 PMID: 8899295
  47. Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor kappa B and interferon regulatory factor 3.
    J Gen Virol. 2003 Sep;84(Pt 9):2491-2495 PMID: 12917470
  48. Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.
    J Virol. 2006 Mar;80(6):3116-21 PMID: 16501125
  49. Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB.
    J Gen Virol. 2000 Dec;81(Pt 12):3011-3020 PMID: 11086132
  50. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10599-603 PMID: 7479848
  51. Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis.
    Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12408-13 PMID: 14530405
  52. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
    J Virol. 2002 Aug;76(16):8468-71 PMID: 12134050
  53. Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3' untranslated region.
    J Immunol. 2001 Aug 15;167(4):2202-8 PMID: 11490006
  54. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation.
    Virology. 2001 Sep 15;288(1):175-87 PMID: 11543670
  55. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.
    J Virol. 1990 Apr;64(4):1704-15 PMID: 2157053
  56. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.
    Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1107-11 PMID: 8381532
  57. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.
    Eur J Biochem. 1984 Aug 15;143(1):165-74 PMID: 6088228
  58. Oscillations in NF-kappaB signaling control the dynamics of gene expression.
    Science. 2004 Oct 22;306(5696):704-8 PMID: 15499023
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2006-06-00
Pages
5113-24
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1472140
Subset
IM
Grants
NIAID NIH HHS · AI 053846 · United States
NIAID NIH HHS · R01 AI020459 · United States
NIAID NIH HHS · AI 20459 · United States
NIAID NIH HHS · R01 AI053846 · United States
NCI NIH HHS · CA 49605 · United States
NCI NIH HHS · P01 CA049605 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]